Mesoblast (ASX:MSB): Which direction will this rollercoaster of a $2bn biotech company go next?
Biotech company Mesoblast (ASX:MSB) is the ultimate definition of a rollercoaster company. As of April 7, 2025, it is capped…
Read More
3 Energy Stocks to Buy That Are Crushing the Market in 2025
The energy sector continues to be one of the most dynamic and influential areas of the stock market. With increasing…
Read More
Is Liquified Natural Gas (LNG) really the clean energy alternative it is made out to be?
In recent years, there has been growing interest in liquified natural gas (LNG) as a potential clean energy alternative by…
Read More